NYMXF
Price:
$0.052
Market Cap:
$4.92M
Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which is in various clinical trials for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. The company also develops and markets NicAlert for detecting tobacco product usage; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. Nymox Pharmaceutical Corporation was...[Read more]
Industry
Biotechnology
IPO Date
1997-12-22
Stock Exchange
OTC
Ticker
NYMXF
According to Nymox Pharmaceutical Corporation’s latest financial reports and current stock price. The company's current ROE is 24.07%. This represents a change of -60.84% compared to the average of 61.47% of the last 4 quarters.
The mean historical ROE of Nymox Pharmaceutical Corporation over the last ten years is -705.40%. The current 24.07% ROE has changed -103.41% with respect to the historical average. Over the past ten years (40 quarters), NYMXF's ROE was at its highest in in the December 2022 quarter at 277.80%. The ROE was at its lowest in in the December 2021 quarter at -3385.54%.
Average
-705.40%
Median
66.30%
Minimum
-15104.82%
Maximum
5.42%
Discovering the peaks and valleys of Nymox Pharmaceutical Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.42%
Maximum Annual ROE = 5.42%
Minimum Annual Increase = -109.03%
Minimum Annual ROE = -15104.82%
| Year | ROE | Change |
|---|---|---|
| 2024 | 66.30% | -76.21% |
| 2023 | 278.73% | -79.57% |
| 2022 | 1.36% | -109.03% |
| 2021 | -15104.82% | 3.42% |
| 2020 | -429.33% | 31.68% |
| 2019 | -326.03% | 142.20% |
| 2018 | -134.61% | -105.34% |
| 2017 | 2.52% | -53.49% |
The current ROE of Nymox Pharmaceutical Corporation (NYMXF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
569.78%
5-year avg
-2764.96%
10-year avg
-705.40%
Nymox Pharmaceutical Corporation’s ROE is less than Hemostemix Inc. (68.24%), greater than HOOKIPA Pharma Inc. (-120.60%), greater than Devonian Health Group Inc. (-33.54%), greater than Algorae Pharmaceuticals Limited (-61.85%), less than EOM Pharmaceuticals Holdings, Inc. (59.97%), less than Sirona Biochem Corp. (221.45%), greater than Inhibitor Therapeutics, Inc. (-337.95%), greater than Oxford BioDynamics Plc (-244.86%), less than ALR Technologies Inc. (51.64%), less than Valeo Pharma Inc. (95.58%),
| Company | ROE | Market cap |
|---|---|---|
| 68.24% | $10.66M | |
| -120.60% | $11.10M | |
| -33.54% | $10.55M | |
| -61.85% | $8.27M | |
| 59.97% | $22.05M | |
| 221.45% | $5.60M | |
| -337.95% | $8.63M | |
| -244.86% | $8.95M | |
| 51.64% | $9.84M | |
| 95.58% | $9.90K |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nymox Pharmaceutical Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Nymox Pharmaceutical Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Nymox Pharmaceutical Corporation's ROE?
How is the ROE calculated for Nymox Pharmaceutical Corporation (NYMXF)?
What is the highest ROE for Nymox Pharmaceutical Corporation (NYMXF)?
What is the 3-year average ROE for Nymox Pharmaceutical Corporation (NYMXF)?
What is the 5-year average ROE for Nymox Pharmaceutical Corporation (NYMXF)?
How does the current ROE for Nymox Pharmaceutical Corporation (NYMXF) compare to its historical average?